Men newly diagnosed with early prostate cancer often would trade some improvement in survival for fewer treatment side effects and a better quality of life.
A new study suggests examining how prostate cancer tumors change, and are expected to change, over time – called tumor evolution – can help determine how aggressive the cancer is and how it should be treated.
Cancer screening is less straightforward than it might seem. Screening isn’t routinely recommended for some cancers, and has confusing guidelines about others.
Should men with intermediate-risk prostate cancer be offered active surveillance as a treatment? Here’s what new research shows.